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inactivation, the non-coding Xist gene, by the key factors which support pluripotency Nanog, Oct4
and Sox2.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. A historical perspective of X-inactivation regulation during cesses characterize X-inactivation: in the extra-embryonic
early mouse development
In mammals, the emergence of a Y chromosome virtually en-
tirely devoted to male sex determination has been associated dur-
ing evolution with the appearance of a dosage compensation
mechanism that equalizes the level of X-linked gene expression
between XY males and XX females. Mary Lyon proposed, based
on cytological and genetic evidence, that to achieve dosage com-
pensation of the X-chromosomes between males and females,
one of the two X-chromosomes is inactivated early in female
embryogenesis [1,2].
Following Lyon’s seminal work, the idea that X-inactivation oc-
curs during cell differentiation became a long-standing concept.
The ﬁrst signs of X-inactivation in the female embryo were thought
to appear early in the ﬁrst tissue to differentiate, the trophoblast,
and only later in tissues of the embryo proper [3]. This schema
was compatible with data suggesting that in the early blastocyst
both X-chromosomes were active in cells of the undifferentiated
inner cell mass (ICM) [4], while in the trophectoderm one X-chro-
mosome in each cell was in an inactive state. Two distinct pro-chemical Societies. Published by E
toderm; PE, primitive endo-
C, embryonic carcinoma; ES,
-inactivation center; Xist, X-
inactive X; ChIP, chromatinlineages, X-inactivation is imprinted with the paternal X-chromo-
some always being chosen for inactivation [5], whereas in cells
of the embryo proper both X-chromosomes are targeted at random
by the inactivation process, through the so-called random X-inac-
tivation. Cellular differentiation therefore appeared to drive X-
inactivation either through imprinted or random mechanisms
depending on the cell lineage in question. A developmental
stem-cell model for X-inactivation was proposed by Monk [6], with
X-inactivation occurring, albeit in different forms, at different
times and in different cell populations as they differentiate from
a pluripotent state. This model was supported by ex vivo X-inacti-
vation studies, initially exploiting the differentiation of female
embryonic carcinoma (EC) cells [7], the stem cells of teratocarcino-
mas, later the differentiation of female embryonic stem (ES) cells
[8], the stem cells derived from the ICM. In both ex vivo systems,
activity of the two X-chromosomes in the female cell is maintained
until cellular differentiation is initiated and random X-inactivation
established, highlighting the existence of a close relationship be-
tween the regulation of lineage commitment and the establish-
ment of X-inactivation. For over 25 years, the view in the ﬁeld
that prevailed based on such results was that during blastocyst for-
mation, imprinted X-inactivation occurs ﬁrst in the trophectoderm
and, subsequently, in the primitive endoderm, whereas both X-
chromosomes remain active in those cells of the ICM that remain
pluripotent. A corollary of this view is that at the onset of the
multi-lineage differentiation of the epiblast that generates the
embryo proper, X-inactivation is established for the ﬁrst timelsevier B.V. All rights reserved.
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throughout development and the entire life of the organism, with
reactivation of the inactive X occurring exclusively in the female
pluripotent germ line [9,10].
Reprogramming experiments further reinforced the idea that X-
inactivation is intimately linked to differentiation. Reactivation of
the inactive X-chromosome carried by female somatic nuclei has
been observed after cell fusion with male EC [11] and ES cells
[12], as well as after nuclear transfer into the enucleated egg
[13]. Importantly, the recent generation of induced pluripotent
stem (iPS) cells by forced expression of ES cell regulators [14]
has also been shown to be accompanied by the reactivation of
the inactive X-chromosome of female somatic cells [15]. Based
on such experiments it appears that X-inactivation is established
when the loss of pluripotency occurs and, reciprocally, that X-inac-
tivation is reversed following the acquisition of pluripotency.
The recent discovery that imprinted X-inactivation takes place
much earlier than predicted by the stem-cell model demonstrates
that the simple association of X-inactivation with cellular differen-
tiation no longer holds. In a clear paradigm shift, three indepen-
dent articles convincingly argued against the conventional view
by demonstrating that X-inactivation initiates several cell divisions
prior to the formation of the blastocyst [16,17]. Imprinted X-inac-
tivation, associated with the exclusive inactivation of the paternalFig. 1. Developmental dynamics of X-inactivation. Imprinted X-inactivation of the
paternal X-chromosome is ﬁrst established at the 2–4-cell transition of early female
embryogenesis. This initial form of X-inactivation is maintained during the
cleavage-stages of the morula, as well as during the differentiation of the
extraembryonic tissues such as the trophectoderm (TE, in pink) and the primitive
endoderm (PE, in purple). The paternal inactive X (Xi) is then reactivated in the
pluripotent cells of the inner cell mass (ICM, in light yellow) of the blastocyst which
allows the establishment of random X-inactivation in the differentiating epiblast
(EPI, in orange). This is the form of X-inactivation that will be maintained in somatic
tissues of the post-implantation embryo and in the adult. The randomly chosen Xi is
reactivated in migrating pluripotent primordial germ cells (PGC, in yellow).X-chromosome, was shown to be implemented in all cells of the
cleavage-stage embryo. This initial form of imprinted X-inactiva-
tion was shown, however, to be labile and at the blastocyst stage,
the paternal X is reactivated in the ICM [16,17]. This results in both
X-chromosomes being active in undifferentiated cells of the ICM
during a short time-window. Subsequently, random X-inactivation
is initiated with either the paternal or the maternal X being chosen
for inactivation. In contrast, X-inactivation remains imprinted in
extra-embryonic tissues. Therefore, the critical developmental reg-
ulation of X-inactivation is based on the reactivation of the pater-
nally-inherited inactive X-chromosome in the ICM, rather than in a
simple coupling of the inactivation and differentiation processes.
Although it is now clear that imprinted X-inactivation is not per
se associated to differentiation, it remains true that random X-
inactivation is linked to the differentiation of the epiblast, as illus-
trated by differentiating female ES cells.
In summary (Fig. 1), during early female mice development, X-
inactivation reprogramming occurs in pluripotent cells of the inner
cell mass of the blastocyst, when imprinted X-inactivation is re-
placed by random inactivation, via a transient stage characterized
by the presence of two active X-chromosomes. Reactivation of the
inactive X also occurs in pluripotent primordial germ cells (PGCs)
and is also observed in vitro, during the reprogramming of female
somatic cells mediated by nuclear cloning, by fusion with EC and
ES cells, and during the generation of iPS cells. Reprogramming
of X-inactivation is therefore associated with the acquisition of
pluripotency both in vivo and in vitro [18].2. Developmental regulation of Xist, the trigger of
X-inactivation
The initiation of X-inactivation is controlled by the X-inactiva-
tion center (Xic), a complex X-linked locus responsible for the inac-
tivation of a single X in female cells and an absence of inactivation
in male cells [19]. The Xist gene lies within the Xic and produces an
essential non-coding RNA with the unique property of coating and
silencing the X-chromosome in cis [20]. Given that only high levels
of Xist RNA can induce X-inactivation, Xist expression has to be
tightly regulated in order to ensure the dynamics of X-inactivation
during development. In pre-implantation embryos, Xist expression
is imprinted and high Xist RNA levels are exclusively produced
from the paternal X-chromosome. Drastic changes in Xist expres-
sion pattern take place in the ICM, where paternal Xist expression
is efﬁciently repressed and this correlates with the reactivation of
the paternal X-chromosome [16,17]. At the onset of random X-
inactivation, Xist is upregulated speciﬁcally on the future inactive
X, irrespectively of its parental origin. Accordingly, in undifferenti-
ated female ES cells, both X-chromosomes produce low levels of
Xist RNA. As the cell differentiates, Xist is mono-allelically upregu-
lated at random to induce X-inactivation in cis, whilst the second
Xist allele of females and the single Xist allele of males are turned
off.
The randomly chosen inactive X-chromosome is also reacti-
vated in the female germ line. Similarly to what has been described
in the ICM, the initial step of the reversion of X-inactivation ap-
pears to be the repression of Xist which occurs in migrating PGCs
[21,22]. Thus, in the germ line, the repression of Xist expression
which leads to the reactivation of the inactive X is again correlated
with the acquisition of pluripotency.
Two aspects of Xist regulation, the levels of Xist RNA and its
chromosomal-origin, appear to be crucial for the developmental
regulation of X-inactivation. In particular, the repression of Xist
expression that characterizes the reprogramming events which
takes place in pluripotent cells appears as a key developmental
event in X-inactivation regulation. This notion is further supported
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the inactive X is similarly associated with the repression of Xist
expression from the inactive X-chromosome [12,15]. We conclude
that some pluripotency-speciﬁc activities must be responsible for
the silencing of Xist and the reactivation of the inactive X.3. Transcriptional aspects of Xist regulation
Using chromatin immunoprecipitation (ChIP) analysis of three
cell types representative of different types and stages of the
X-inactivation process, we reported major variations in the tran-
scriptional machinery recruitment activity of the Xist promoter
that correlate with the X-inactivation status of the corresponding
chromosome [23]. The levels of transcription basal machinery
associated with the Xist promoter in cell types expressing high lev-
els of Xist RNA, in which X-inactivation has already occurred (at
random in female mouse embryonic ﬁbroblasts, or imprinted in
trophectoderm stem cells) is considerably greater than the levels
detected in cells expressing low levels of Xist, in which X-inactiva-
tion has yet to occur, such as ES cells. This indicates that Xist
expression is regulated transcriptionally by the selective recruit-
ment of the transcriptional apparatus to its promoter. Analysis of
Xist transcription by nuclear run-on experiments carried out in
ES cells conﬁrmed that Xist transcription is essentially absent prior
to differentiation but strongly upregulated on differentiation [24].
The observed correlation in ES cells between low steady state
levels of Xist RNA, the presence of limiting amounts of the
transcriptional apparatus at the Xist promoter, and inefﬁcient Xist
transcription, suggested strongly either the presence of a transcrip-
tional repressor or the lack of a speciﬁc transcriptional activator in
such cells. Importantly, the repression of Xist transcription in ES
cells might be part of the mechanism allowing the reactivation of
the paternal X-chromosome in the ICM, and by extrapolation, in
other pluripotent stem cells.
One of the most exciting characteristics of the Xist gene is its
complete overlap by a non-coding antisense transcription unit,
Tsix, shown to act as a crucial cis-acting repressor of Xist upregula-
tion: a tight correlation between antisense downregulation and
Xist RNA accumulation during random X-inactivation has previ-
ously been established [25]. Both deletion of the major Tsix pro-
moter and truncation of the antisense transcription unit leads to
a complete bias in random X-inactivation towards the mutated
allele [26]. This strongly suggests that Tsix is likely involved in
the chromosomal-origin of Xist expression during random X-inac-
tivation. It has similarly been proposed that Tsix is responsible for
the paternal-restricted expression of Xist in extra-embryonic
tissues exhibiting imprinted X-inactivation [27], although the role
of Tsix in the early, reversible imprinted Xist expression encoun-
tered in the cleavage-stages of the morula has yet to be clearly
addressed.
Given the repressive nature of Tsix transcription across Xist, it
was tempting to propose that Tsix is the crucial repressor of Xist
transcription in undifferentiated ES cells, in which Tsix is highly
transcribed. This would suggest that, in addition to its role in the
establishment of the appropriate chromosomal-origin of Xist tran-
scription, Tsix would also be responsible for the suppression of Xist
transcription in pluripotent stem cells. Whilst Tsix is highly tran-
scribed in the ICM, and its transcription efﬁciently restored during
in vitro reprogramming of female somatic cells [12,15], it cannot,
however, be the developmentally regulated, pluripotency-speciﬁc,
repressor of Xist. Indeed, Xist transcription remains repressed in
undifferentiated Tsix-mutant ES cells, as evaluated both by ChIP
analysis of the transcriptional machinery at the Xist promoter
[23] and by nuclear run-on evaluation of Xist transcription rate
[24]. In addition, normal reactivation of the paternal X-chromo-some in the ICM has been reported in the context of a pater-
nally-inherited invalidation of Tsix [28]. The lack of Tsix
transcription observed in female PGCs [22], where Xist transcrip-
tion is repressed and the randomly chosen inactive X-chromosome
reactivated, further indicates that Tsix cannot be the sought after
general Xist repressor in pluripotent cells.
What then are the other molecular signatures speciﬁc to plurip-
otent cells that might act as the developmental repressors of Xist
transcription specifying X-inactivation reprogramming in pluripo-
tent cells?4. Direct molecular coupling of Xist repression and pluripotency
in ES cells
Three transcription factors, Nanog [29,30], Oct4 [31] and Sox2
[32], are known to be essential for the triggering and maintenance
of the pluripotent phenotype. Given the profound epigenetic repro-
gramming that accompanies the acquisition of pluripotency, it was
previously thought that the transcriptional repression of Xist and
the reactivation of the inactive X-chromosome were likely second-
ary reﬂections of the pluripotent state [17,18]. Thus, X-inactivation
reprogramming was view as an indirect epigenetic consequence of
the action of Nanog, Oct4 and Sox2. The ﬁnding that the triumvirate,
Nanog, Oct4 and Sox2, bind directly to the chromatin of the Xist
gene in undifferentiated ES cells to maintain Xist repression prior
to the onset of differentiation [33] argues against this view.
Using ChIP analysis, we demonstrated that Nanog, Oct4 and
Sox2 bind Xist intron 1 in both male and female undifferentiated
ES cells. The binding of the three factors was found to be sharply
reduced in differentiating ES cells, and undetectable in fully differ-
entiated mouse embryonic ﬁbroblasts. Importantly, binding of the
three factors was shown to be independent of Tsix transcription, as
expected for Tsix-independent regulators of Xist. Thus, three devel-
opmentally regulated transcription factors, whose own function is
dedicated to pluripotency, bind the Xist locus with all the charac-
teristics required for the pluripotency-speciﬁc, Tsix-independent,
repressor of Xist transcription [33].
The ﬁnding that the Xist gene is a direct target for Oct4, Nanog
and Sox2 suggests that these pluripotency-associated transcrip-
tional regulators are directly responsible for Xist repression in
pluripotent cells. Testing this hypothesis in female ES cells is,
however, difﬁcult, as knock-out or knock-down of these factors
can induce or commit such cells to cell differentiation with, as a
consequence, the triggering of Xist upregulation and X-inactiva-
tion. In contrast, in differentiating male ES cells Xist expression is
never normally upregulated because additional activities of the
Xic inhibit the initiation of X-inactivation [19]. Genetic manipula-
tion which resulted in the abrogation of the expression of one or
other of the pluripotent factors and which resulted in the inappro-
priate regulation of Xist in male cells would reveal and conﬁrm an
eventual intimate relationship existing between the master genes
of pluripotency and Xist. The analysis of male ES cells in which Na-
nog was homozygously deleted [34] showed that mutation of Na-
nog alone caused a moderate increase in Xist expression, whilst
Oct4 and Sox2 remained bound, potentially preventing more com-
plete activation of Xist transcription [33]. Importantly, this modest
upregulation of Xist observed in Nanog/ cells is an early conse-
quence arising after Nanog deletion and is independent of Tsix
downregulation. Restoration of Nanog by homologous recombina-
tion mediated rescue of Nanog/ cells is accompanied by a
repression of Xist expression levels to those of wild-type cells.
Genetic invalidation of Oct4was previously shown to induce the
complete loss of pluripotency [35]. Accordingly, in an inducible
Oct4 invalidation system [35], silencing of Oct4 in male ES cells
triggers the drastic loss from Xist intron 1 not only of Oct4, but also
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crease in Xist expression to a level similar to that seen in differen-
tiating female ES cells, which precedes any measurable
downregulation of Tsix [33]. It appears, therefore, that Nanog,
Oct4 and Sox2 synergize to repress Xist transcription in undifferen-
tiated ES cells independently of Tsix transcription. The Tsix-inde-
pendency of the repressive action of Nanog, Oct4 and Sox2 on
Xist is further supported by the upregulation of Xist transcription
observed in Tsix-mutant ES cells both upon loss of pluripotency in-
duced by differentiation [24,33,36] and by siRNA knock-down of
Oct4 (PN unpublished observations).
Finally, it has been observed that Xist is upregulated in un-
differentiated male ES cells in which a part of Xist exon 1 has been
replaced with a promoter-less IRES-EGFP cassette [37]. Impor-
tantly, in these mutant ES cells, Tsix was not downregulated. This
suggests that the genetic alteration introduced at the Xist locus
impaired the ES cell-speciﬁc, Tsix-independent, silencing mecha-
nism of Xist. These unexpected observations lead the authors to
hypothese that the deleted region might contain a cis regulatory
element required for Xist-silencing in undifferentiated cells [37].
Interestingly, the 30 boundary of the replaced sequence lies within
Xist intron 1. Fine mapping of the deletion boundary in respect to
the pcr amplicon providing maximal binding of Nanog, Oct4 and
Sox2 in ChIP assays [33] suggests that in such mutant cells binding
of the three factors might be disrupted. Localization of Nanog,
Oct4 and Sox2 binding sites within Xist intron 1 using published
ChIP-Seq [38] also indicates that the Nanog and Oct4 binding sites
have been removed in the mutant cells. We conclude that deletion
of the binding sequences for Nanog and Oct4 within Xist intron
1 induce Xist upregulation in the absence of any measurable
downregulation of Tsix, in agreement with our results [33]. Future
experiments speciﬁcally deleting Xist intron 1 will, however, be
needed to conﬁrm these observations.
We conclude that the basic molecular framework for Xist regu-
lation in ES cells depends on the repression of Xist transcription
that is ensured by the direct repressive action of Nanog, Oct4 and
Sox2. Our observations provide novel explanations for both the
old observation that random X-inactivation is associated with dif-
ferentiation, and for the association of the phenomena of X-inacti-
vation reprogramming with the acquisition of pluripotency. In the
following two sections we provide two non-mutually exclusive
hypotheses that seek to provide a framework for integrating Xist
regulation by Nanog, Oct4 and Sox2 with the biology of the ICM
and germ cells.Fig. 2. Hypothetical scenario of the ordered recruitment of Nanog, Oct4 and Sox2 at
Xist intron 1 during early embryogenesis. (A) During the cleavage-stages of the
morula, Xist is highly expressed from the paternal X-chromosome although Oct4 (in
blue) and Sox2 (in green) are expressed. We suggest here that Oct4 and Sox2 cannot
repress Xist at this stage because their cognate binding sequences is masked by the
nucleosomal array (in gray) spanning Xist intron 1. (B) Nanog is ﬁrst expressed in
some internal cells of the late morula, where it binds to Xist intron 1 and recruits
chromatin remodeling complexes such as SWI/SNF (in yellow). (C) During the
formation of the blastocyst, Xist intron 1 chromatin is reorganized to unmask the
cognate binding sequences for Oct4 and Sox2. (D) In the ICM of early blastocysts,
Oct4 and Sox2 can be recruited to Xist intron 1 to suppress Xist transcription
efﬁciently, and allow the reactivation of the inactive paternal X-chromosome. See
text for details.5. Nanog, Oct4 and Sox2 as the genetic factors specifying Xist
repression in pluripotent cells
Nanog, Oct4 and Sox2 confer on Xist the expression pattern
appropriate to undifferentiated ES cells. We therefore propose that
they suppress Xist expression in cells of all the pluripotent com-
partments of the early embryo including both the ICM and PGCs.
In the ICM, paternal X-inactivation is reverted and random X-inac-
tivation prepared [16,17], suggesting that Nanog, Oct4 and Sox2
play a direct pivotal role in this process through the transient
repression of Xist transcription. Interestingly, although Oct4 and
Sox2 are expressed in all cleavage-stages of the morula before their
expression becomes progressively conﬁned to the ICM during blas-
tocyst formation [18], the ﬁrst cells to reactivate the paternal inac-
tive X-chromosome are those internal cells of the late morula that
establish Nanog expression [16]. Similarly, although Oct4 and Sox2
are expressed during the initial stages of PGCs development, the
repression of Xist expression and the reactivation of the inactive
X-chromosome is not initiated until Nanog is re-expressed
[21,22]. These results, which suggest that Xist repression coincidestemporally and spacially with the acquisition of pluripotency, indi-
cate that Nanog probably plays the preponderant role in the repres-
sion of Xist.
Surprisingly in this context, in Nanog-null undifferentiated ES
cells Oct4 and Sox2 remain bound to Xist intron 1, and Xist tran-
scription remains strongly repressed. Conversely upon Oct4 silenc-
ing, both Nanog and Sox2 are lost from Xist intron 1 before
dowregulation of their respective mRNAs, indicating that Oct4
must be required for maintaining the binding of Nanog and Sox2
at Xist [33]. It appears, therefore, that the principles governing
binding of Nanog, Oct4 and Sox2 at Xist intron 1 in ES cells may dif-
fer from what would be expected from a simple correlative analy-
sis of Xist, Nanog, Oct4 and Sox2 expression during early
embryogenesis (Fig. 2). It is noteworthy that this apparent paradox
is not speciﬁc to the regulation of Xist, as it also emerges from a
consideration of the differential in vivo and ex vivo requirements
of the pluripotent phenotype for Nanog. For example whilst Nanog
can be removed from ES cells without severely affecting pluripo-
tency [34], the absence of Nanog during early embryogenesis in-
duces a failure to establish pluripotent stem cells in the ICM [30]
and during PGC development [34]. Similarly, although Nanog is dis-
pensable for reprogramming somatic cells back to pluripotency by
ectopic expression of a minimal cocktail of transcription factors
including Oct4 and Sox2, full pluripotency and repression of Xist
is not acquired until the endogenous Nanog gene is re-expressed.
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duce and establish pluripotency, rather than to maintain such a
state [34]. Accordingly, Nanog has been shown to promote transfer
of pluripotency after cell fusion [39]. Nanog might therefore play a
crucial role in the establishment of Xist repression, but not neces-
sarily in its maintenance. It seems therefore reasonable to propose
that Oct4 and Sox2 are able to repress Xist transcription only in
Nanog-positive cells of the late morula and migrating PGCs, and
that it is this that leads to the complete extinction of Xist RNA
and to the reversion of the inactive X-chromosome to the tran-
scriptional ground state which characterizes both X-chromosomes
in the ICM and in germ cells. This would also explain why Xist is
not repressed during the generation of iPS cells until Nanog is
re-expressed [15].
Under this model, it is only when Nanog binds to Xist intron 1
that Sox2 and Oct4 either can be recruited or become functional
for repressing Xist, after which their action becomes Nanog-inde-
pendent. A likely mechanism (Fig. 2) could involve a Nanog-depen-
dent re-organization of Xist intron 1 chromatin to render accessible
for binding the cognate Oct4 and Sox2 DNA binding sequences.
Interestingly, a developmentally regulated DNAse hypersensitivity
site has been shown to characterize Xist intron 1 in undifferenti-
ated ES cells [40], and the BAF155 partner of the nucleosome
remodeling machinery SWI/SNF is found in Nanog-related protein
complexes [41].Fig. 3. Hypothetical holistic scenario of Nanog, Oct4 and Sox2 action at Xist during
early embryogenesis. (A) We suggest here that Oct4 and Sox2 binding sites are
differentially methylated (black circles) during gametogenesis, with exclusive
methylation at Xist intron 1occurring during spermatogenesis. This blocks binding
of Oct4 (in blue) and Sox2 (in green) at Xist intron 1 in the Xist-expressing male
gametes but not in the Xist-repressed female gametes. (B) During the cleavage-
stages of the morula, the methylation imprint of Xist intron 1 is protected against
the active demethylation of the paternal genome, restricting binding of Oct4 and
Sox2 to the maternal allele. This underlies paternally-restricted Xist transcription.
(C) Nanog (in red), which is not expressed in the gametes, is ﬁrst expressed in
internal cells of the late morula, where it is able to bind to Xist intron 1
independently of the methylation imprint. (D) In the ICM, Nanog erases the paternal
imprint rendering the paternal Xist allele competent for Oct4 and Sox2 binding. This
leads to the repression of paternal Xist and to the reactivation of the inactive
paternal X-chromosome. See text for details.6. A holistic potential role for Nanog, Oct4 and Sox2 in the
control of Xist expression during pre-implantation
development
The integration of the dynamics of X-inactivation with early
developmental transitions can also be envisaged using an alterna-
tive hypothesis, in which Oct4 and Sox2 would drive imprinted Xist
transcription during the cleavage-stages of the morula (Fig. 3). In-
deed, rather than assuming that Oct4 and Sox2 are not able to re-
press Xist at these stages because the paternal X-chromosome
expresses high levels of Xist, it remains possible that, in fact, Oct4
and Sox2 repressive action on Xist is restricted to the maternally-
inherited Xist allele which remains silent during pre-implantation
development. In this case, an as yet unknown imprinting mark
responsible for paternally-restricted Xist transcription would block
binding of Oct4 and Sox2 to the paternal, but not to the maternal
Xist locus, therefore providing the basis for the paternally-re-
stricted transcription of Xist. Binding of Nanog to Xist intron 1 in
the internal cells of the morula would erase this mark and stimu-
late binding of Oct4 and Sox2 to both Xist alleles. This would result
in the bi-allelic repression of Xist by the three pluripotent factors,
and the progressive reactivation of the paternal inactive X-chromo-
some in the ICM. Once the imprint is erased by Nanog, both Oct4
and Sox2 would bind at Xist even in the absence of Nanog, in agree-
ment with the observations reported in Nanog-null ES. Under this
scenario, Nanog function would be more related to the reprogram-
ming of the epigenetic information specifying imprinted Xist tran-
scription, and to rendering the paternal Xist locus competent to
bind Oct4 and Sox2, than to the transcriptional repression of Xist
per se. Following up on the idea that Nanog acts as a reprogrammer
of the imprint responsible for paternal-restricted Xist transcription,
it is interesting to note that during PGCs development Nanog-null
cells die around day 11.5 post coitum [34], when DNA demethyla-
tion and erasure of imprinting marks is performed in the germ line
[18,42]. An interesting working hypothesis based on the predicted
function of Nanog in the erasure of the putative paternal imprint
blocking binding of Oct4 and Sox2 to the paternal Xist intron 1,
would involve the generalization of Nanog’s role to the systematic
erasure of imprints that occur in the germ line.Interestingly, Nanog is present in neither male or female mature
gametes [43] whereas both Oct4 and Sox2 are present in the oocyte
and epigenetically inherited in the zygote as maternal components
[32,44]. Moreover, the presence of Oct4 and Sox2 in the oocyte cor-
relates with a lack of Xist transcription at this stage [45]. One pos-
sibility is that the maternal Xist allele is inherited with both Oct4
and Sox2 already bound to Xist intron 1, providing a simple plat-
form for establishing maternal Xist-silencing at the time of zygotic
genome activation. Conversely, Xist has been shown to be ex-
pressed during spermatogenesis [45] although it has been shown
not to be responsible for the meiotic inactivation of the XY-body
that characterizes male gametes [46]. In addition, it has been
shown that some Oct4 and Sox2 binding sites are speciﬁcally hy-
per-methylated in male germ cells, the testes, and in isolated
sperm [47]. Strikingly, this hypermethylation of Oct4 and Sox2
binding sites in germ cells was correlated with an absence of
Oct4 and Sox2 binding, as evaluated by ChIP [47]. It is unknown
whether Oct4 and Sox2 binding sites at Xist intron 1 are hyper-
methylated in the sperm, but if this were the case, then it would
be possible that this methylation underlines the expression of Xist
that occurs during male gametogenesis. Further, if the methylation
of Xist intron 1 established in male gametes were protected against
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during the cleavage-stages of the morula [42], as described for
other imprinted genes such as H19 and Rasgrf1, then binding of
Oct4 and Sox2 would be blocked on the paternal Xist allele effec-
tively allowing transcription of the paternal Xist allele during
pre-implantation stages.
In summary (Fig. 2), we propose here as a testable hypothesis
that the Oct4/Sox2 binding sites at Xist intron 1 are differentially
methylated in female and male gametes, and that this underlies
the lack of binding of Oct4 and Sox2 to the paternally-inherited Xist
allele during pre-implantation development. This implies that
binding of Nanog must somehow induce the loss of the methyla-
tion imprint. It cannot, however, be excluded that Xist intron 1
methylation is erased in the ICM independently of Nanog but coin-
cident with Nanog expression. We expect current testing of this
hypothesis to markedly clarify our understanding of Xist regulation
during early mouse embryogenesis.7. Epigenetic resetting of Xist chromatin in the ICM: rendering
all Xist alleles epigenetically indistinguishable
We propose that the binding of Nanog, Oct4 and Sox2 at Xist in-
tron 1 forms the molecular basis responsible for the suppression of
Xist transcription in pluripotent cells, probably through the repres-
sion of the transcriptional machinery recruitment activity of the
Xist promoter. This could, however, be insufﬁcient to allow the
appropriate transition from imprinted to random Xist transcription
that occurs in the ICM. In both imprinted and random post-X-inac-
tivation cells, the active Xist allele has been shown to be epigenet-
ically marked by histone marks associated with euchromatin,
whereas the silent Xist promoter on the active X-chromosome is
not [23,36]. These marks are believed to allow the maintenance
through mitotic cell division of the established chromosomal-ori-
gin of Xist transcription. This suggests that in the ICM the chroma-
tin of the promoter region of both Xist alleles could carry marks
associated with imprinted Xist transcription, with the paternal Xist
promoter inheriting a euchromatic state that could favor the re-
establishment of its activation once Nanog, Oct4 and Sox2 are
repressed, unless these were erased. Both the establishment of
random X-inactivation in the epiblast, the random upregulation
of Xist in female iPS cells upon differentiation [15], and an apparent
absence of differential chromatin marks in female ES cells [36]
indicate that such chromatin marks are likely erased during
reprogramming, prior to their random re-establishment during
differentiation. These observations suggest that in pluripotent
cells, or at least in those of the ICM and in those obtained
in vitro, the inherited state of Xist promoter chromatin is reset to
render both Xist promoters epigenetically indistinguishable and
equally competent for activation at the onset of differentiation.
Although Tsix does not directly repress Xist transcription in ES
cells, antisense transcription across Xist has been shown to induce
complex chromatin modiﬁcations [23,24,36,48]. In particular, Tsix
has been shown to trigger the acquisition of marks associated with
gene silencing in undifferentiated ES cells, such as H3K9me3 and
CpG methylation, to a CTCF-ﬂanked region of the Xist promoter,
blocking in turn any enrichment for euchromatin-associated marks
[36]. In the absence of Tsix, the CTCF-ﬂanked Xist promoter chro-
matin shifts into euchromatin, but this is not accompanied by in-
creased levels of transcriptional machinery recruitment until the
cell differentiates [36] and Nanog, Oct4 and Sox2 are lost from Xist
intron 1 [33]. Therefore, Tsix transcription, or the produced RNA
itself, acts as a Xist promoter chromatin modiﬁer responsible for
the inhibition of euchromatin-associated histone marks.
Tsix, which is highly transcribed from both the paternal and
maternal X-chromosomes in the ICM, in ES cells, and in iPS cells,could therefore be essential to the resetting of the chromatin
marks required to support the mono-allelic recruitment of the
transcriptional machinery at either the paternal Xist promoter dur-
ing pre-implantation, and at the Xist promoter of the randomly
chosen inactive X-chromosome of somatic female cells submitted
to in vitro genome reprogramming. This chromatin remodeling
activity of Tsix would be involved in providing at both Xist alleles
the epigenetic ground state required to establish, following loss
of Nanog, Oct4 and Sox2, new allelic differences supporting
mono-allelic Xist transcription.
In conclusion, we propose that the repression of Xist transcrip-
tion in pluripotent cells, notably in the ICM, is dependent on the
repressive action of Nanog, Oct4 and Sox2 on the one hand, ulti-
mately responsible for the control of Xist transcription rate, and
on Tsix-mediated chromatin modiﬁcations, which reset both Xist
alleles to an identical ground state of epigenetic information by
erasing inherited marks associated with imprinted (or random in
the case of genome reprogramming in vitro) Xist transcription on
the other. During differentiation, the natural loss of the pluripotent
factors that repress Xist, and the initial mono-allelic silencing of
Tsix that designates the future inactive X-chromosome [25], opens
a window of opportunity for both the re-establishment of an
euchromatic structure and the recruitment of the transcriptional
machinery at the Xist promoter of the future inactive X-chromo-
some. It will be important, in the future, to understand how Tsix
transcription is speciﬁcally established and maintained at high lev-
els in the ICM, in ES cells, and in iPS cells.8. Concluding remarks
We have argued in this review that the connection between
early developmental transitions and the regulation of X-inactiva-
tion, in particular the systematic repression of Xist and the reacti-
vation of the inactive X-chromosome that occurs in pluripotent cell
compartments, is directly speciﬁed by the repressive action that
Nanog, Oct4 and Sox2, the triumvirate of factors supporting pluri-
potency, exert on Xist transcription. This does not, however, imply
that current ideas suggesting that X-inactivation reprogramming is
a reﬂection of the pluripotent phenotype on the overall epigenetic
state of the inactive X-chromosome are totally redundant. A key
observation in this respect is that Xist can be deleted from the inac-
tive X-chromosome of female MEFs without triggering anything
other than a minor and very localized reactivation of X-linked
genes [49]. Although it is suspected that the inactive state of the
paternal X-chromosome characterizing early embryogenesis is
not as stable as that of somatic cells, the suppression of Xist tran-
scription by Nanog, Oct4 and Sox2, and the accompanying loss of
Xist RNA may not on its own be sufﬁcient to reactivate the inactive
X-chromosome, in particular during both PGC development and
iPS generation. Additional particularities of pluripotent cells, possi-
bly involving speciﬁc chromatin-related activities, may be involved
in facilitating the reactivation of the inactive X-chromosome along
with the suppression of Xist transcription by Nanog, Oct4 and Sox2.
Similarly, it cannot be excluded that additional factors other
than Nanog, Oct4 and Sox2 may play a role in Xist upregulation
during the random X-inactivation process that takes place in the
early post-implanted epiblast. The recent demonstration that fe-
male pluripotent epiblast derived stem (EpiS) cells are character-
ized by random X-inactivation and high Xist expression [50]
concomitant with the expression of Nanog, Oct4 and Sox2, sug-
gests that additional levels of complexity may be involved in the
establishment of random X-inactivation in the period prior to the
long-term silencing of Nanog, Oct4 and Sox2. This could occur
through distinct, non-mutually exclusive strategies, such as the
blocking of the binding of these factors within Xist intron 1, or
P. Navarro, P. Avner / FEBS Letters 583 (2009) 1721–1727 1727some other inhibition of their activity. Alternatively, yet unknown
activities could render the Xist promoter insensitive to their action,
or restrict the interaction of Nanog, Oct4 and Sox2 to the Xist allele
that has been elected to remain silent. It is noteworthy that human
ES cells are arguably more related to mouse EpiS cells than to
mouse ES cells. If the plasticity of X-inactivation reported in human
ES cells [51] turns out to apply to mouse EpiSC cells, it will be
tempting to see this as the result of the inconsistent and capricious
repression of Xist mediated by the pluritency factors. Additional
intersections between the road to pluripotency and the path of
X-inactivation regulation are clearly to be expected.
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